168 related articles for article (PubMed ID: 23478198)
1. Docetaxel-associated palmar-plantar erythrodysesthesia: a case report and review of the literature.
Harris CS; Wang D; Carulli A
J Oncol Pharm Pract; 2014 Feb; 20(1):73-80. PubMed ID: 23478198
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel induced severe palmar plantar erythrodysesthesia.
Kharmoum S; Errihani H
Pan Afr Med J; 2018; 30():70. PubMed ID: 30344854
[No Abstract] [Full Text] [Related]
3. Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08).
Templeton AJ; Ribi K; Surber C; Sun H; Hsu Schmitz SF; Beyeler M; Dietrich D; Borner M; Winkler A; Müller A; von Rohr L; Winterhalder RC; Rochlitz C; von Moos R; Zaman K; Thürlimann BJ; Ruhstaller T;
Breast; 2014 Jun; 23(3):244-9. PubMed ID: 24656636
[TBL] [Abstract][Full Text] [Related]
4. Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report.
Kigen G; Busakhala N; Njiru E; Chite F; Loehrer P
Pan Afr Med J; 2015; 21():228. PubMed ID: 26523170
[TBL] [Abstract][Full Text] [Related]
5. Severe palmar-plantar erythrodysesthesia and aplasia in an adult undergoing re-induction treatment with high-dose cytarabine for acute myelogenous leukemia: a possible drug interaction between posaconazole and cytarabine.
Alzghari SK; Seago SE; Cable CT; Herrington JD
J Oncol Pharm Pract; 2017 Sep; 23(6):476-480. PubMed ID: 27530244
[TBL] [Abstract][Full Text] [Related]
6. Palmar-plantar erythrodysesthesia secondary to docetaxel chemotherapy: a case report.
Benghiat H; Al-Niaimi A
J Med Case Rep; 2011 Feb; 5():80. PubMed ID: 21352522
[TBL] [Abstract][Full Text] [Related]
7. Liposomal doxorubicin-related palmar-plantar erythrodysesthesia (hand-foot syndrome): a case report.
Ni C; Fang J; Qian H; Xu Q; Shen F
J Int Med Res; 2020 Dec; 48(12):300060520974854. PubMed ID: 33356712
[TBL] [Abstract][Full Text] [Related]
8. Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment.
Farr KP; Safwat A
Case Rep Oncol; 2011 Apr; 4(1):229-35. PubMed ID: 21537373
[TBL] [Abstract][Full Text] [Related]
9. Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.
Kara IO; Sahin B; Erkisi M
Breast; 2006 Jun; 15(3):414-24. PubMed ID: 16188440
[TBL] [Abstract][Full Text] [Related]
10. A case of docetaxel-induced erythrodysesthesia.
Katoh M; Kadota M; Nishimura Y
J Dermatol; 2004 May; 31(5):403-6. PubMed ID: 15187308
[TBL] [Abstract][Full Text] [Related]
11. An exploratory study to identify risk factors for the development of capecitabine-induced Palmar Plantar Erythrodysesthesia (PPE).
Law A; Dyson S; Anthony D
J Adv Nurs; 2015 Aug; 71(8):1825-32. PubMed ID: 25702709
[TBL] [Abstract][Full Text] [Related]
12. Palmar-plantar erythrodysesthesia associated with high-dose methotrexate: Case report.
Chauhan P; Gupta A; Kumar S; Bishnu A; Nityanand S
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1270. PubMed ID: 32767666
[TBL] [Abstract][Full Text] [Related]
13. Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer.
Eich D; Scharffetter-Kochanek K; Eich HT; Tantcheva-Poor I; Krieg T
Am J Clin Oncol; 2002 Dec; 25(6):599-602. PubMed ID: 12478008
[TBL] [Abstract][Full Text] [Related]
14. [Hand-foot syndrome (palmar-plantar erythrodysesthesia].
Salzberg M; Herrmann R
Schweiz Med Wochenschr; 2000 Oct; 130(40):1413-6. PubMed ID: 11059033
[TBL] [Abstract][Full Text] [Related]
15. Palmar-plantar erythrodysesthesia.
Gupta A; Mehta A; Khanna S
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26359464
[No Abstract] [Full Text] [Related]
16. Hand-foot syndrome induced by chemotherapy drug: Case series study and literature review.
Zaiem A; Hammamia SB; Aouinti I; Charfi O; Ladhari W; Kastalli S; Aidli SE; Lakhoua G
Indian J Pharmacol; 2022; 54(3):208-215. PubMed ID: 35848692
[TBL] [Abstract][Full Text] [Related]
17. Influence of Chemotherapy on the Antioxidant Status of Human Skin.
Lee BN; Jung S; Darvin ME; Eucker J; Kühnhardt D; Sehouli J; Chekerov R; Patzelt A; Fuss H; Yu RX; Lademann J
Anticancer Res; 2016 Aug; 36(8):4089-93. PubMed ID: 27466518
[TBL] [Abstract][Full Text] [Related]
18. Fatal palmar-plantar erythrodysesthesia after clofarabine and cytarabine chemotherapy.
Hwang YY; Trendell-Smith NJ; Yeung CK; Kwong YL
Acta Haematol; 2012; 128(3):151-3. PubMed ID: 22890199
[No Abstract] [Full Text] [Related]
19. Docetaxel-induced palmoplantar erythrodysesthesia syndrome and long-lasting multiple nail changes.
Akoglu G
Indian J Pharmacol; 2014; 46(2):225-7. PubMed ID: 24741199
[TBL] [Abstract][Full Text] [Related]
20. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with taxotere.
Vukelja SJ; Baker WJ; Burris HA; Keeling JH; Von Hoff D
J Natl Cancer Inst; 1993 Sep; 85(17):1432-3. PubMed ID: 8102408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
